{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:21:02Z","timestamp":1780597262434,"version":"3.54.1"},"reference-count":56,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>CD19 chimeric antigen receptor T-cell therapy (CD19-CAR) has changed the treatment landscape and outcomes for patients with pre\u2013B-cell acute lymphoblastic leukemia (B-ALL). Unfortunately, primary nonresponse (PNR), sustained CD19+ disease, and concurrent expansion of CD19-CAR occur in 20% of the patients and is associated with adverse outcomes. Although some failures may be attributable to CD19 loss, mechanisms of CD19-independent, leukemia-intrinsic resistance to CD19-CAR remain poorly understood. We hypothesize that PNR leukemias are distinct compared with primary sensitive (PS) leukemias and that these differences are present before treatment. We used a multiomic approach to investigate this in 14 patients (7 with PNR and 7 with PS) enrolled in the PLAT-02 trial at Seattle Children\u2019s Hospital. Long-read PacBio sequencing helped identify 1 PNR in which 47% of CD19 transcripts had exon 2 skipping, but other samples lacked CD19 transcript abnormalities. Epigenetic profiling discovered DNA hypermethylation at genes targeted by polycomb repressive complex 2 (PRC2) in embryonic stem cells. Similarly, assays of transposase-accessible chromatin\u2013sequencing revealed reduced accessibility at these PRC2 target genes, with a gain in accessibility of regions characteristic of hematopoietic stem cells and multilineage progenitors in PNR. Single-cell RNA sequencing and cytometry by time of flight analyses identified leukemic subpopulations expressing multilineage markers and decreased antigen presentation in PNR. We thus describe the association of a stem cell epigenome with primary resistance to CD19-CAR therapy. Future trials incorporating these biomarkers, with the addition of multispecific CAR T cells targeting against leukemic stem cell or myeloid antigens, and\/or combined epigenetic therapy to disrupt this distinct stem cell epigenome may improve outcomes of patients with B-ALL.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022008977","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T13:17:22Z","timestamp":1673011042000},"page":"4218-4232","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":15,"title":["A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0809-668X","authenticated-orcid":false,"given":"Katherine E.","family":"Masih","sequence":"first","affiliation":[{"name":"1Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"},{"name":"2Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Cambridge, England"},{"name":"3Medical Scientist Training Program, University of Miami Leonard M. Miller School of Medicine, Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Gardner","sequence":"additional","affiliation":[{"name":"4Department of Pediatrics, University of Washington School of Medicine, Seattle, WA"},{"name":"5Center for Clinical and Translational Research, Seattle Children\u2019s Research Institute, Seattle, WA"},{"name":"6Ben Towne Center for Childhood Cancer Research, Seattle Children\u2019s Research Institute, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4870-9663","authenticated-orcid":false,"given":"Hsien-Chao","family":"Chou","sequence":"additional","affiliation":[{"name":"1Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalla","family":"Abdelmaksoud","sequence":"additional","affiliation":[{"name":"1Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"},{"name":"7Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Frederick, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young K.","family":"Song","sequence":"additional","affiliation":[{"name":"1Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3502-7364","authenticated-orcid":false,"given":"Luca","family":"Mariani","sequence":"additional","affiliation":[{"name":"8Division of Genetics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineela","family":"Gangalapudi","sequence":"additional","affiliation":[{"name":"1Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0130-2302","authenticated-orcid":false,"given":"Berkley E.","family":"Gryder","sequence":"additional","affiliation":[{"name":"1Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"},{"name":"9Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4440-001X","authenticated-orcid":false,"given":"Ashley L.","family":"Wilson","sequence":"additional","affiliation":[{"name":"6Ben Towne Center for Childhood Cancer Research, Seattle Children\u2019s Research Institute, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2112-1288","authenticated-orcid":false,"given":"Serifat O.","family":"Adebola","sequence":"additional","affiliation":[{"name":"10Immunodynamics Group, Cancer and Inflammation Program, Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2613-2955","authenticated-orcid":false,"given":"Benjamin Z.","family":"Stanton","sequence":"additional","affiliation":[{"name":"11Center for Childhood Cancer and Blood Diseases, Nationwide Children\u2019s Hospital, Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyu","family":"Wang","sequence":"additional","affiliation":[{"name":"1Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9778-8548","authenticated-orcid":false,"given":"David","family":"Milewski","sequence":"additional","affiliation":[{"name":"1Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5417-9232","authenticated-orcid":false,"given":"Yong Yean","family":"Kim","sequence":"additional","affiliation":[{"name":"1Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0547-9447","authenticated-orcid":false,"given":"Meijie","family":"Tian","sequence":"additional","affiliation":[{"name":"1Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam Tai-Chi","family":"Cheuk","sequence":"additional","affiliation":[{"name":"1Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8233-5418","authenticated-orcid":false,"given":"Xinyu","family":"Wen","sequence":"additional","affiliation":[{"name":"1Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[{"name":"6Ben Towne Center for Childhood Cancer Research, Seattle Children\u2019s Research Institute, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9602-8133","authenticated-orcid":false,"given":"Gr\u00e9goire","family":"Altan-Bonnet","sequence":"additional","affiliation":[{"name":"10Immunodynamics Group, Cancer and Inflammation Program, Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0654-2778","authenticated-orcid":false,"given":"Michael C.","family":"Kelly","sequence":"additional","affiliation":[{"name":"12Center for Cancer Research Single Cell Analysis Facility, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4812-0250","authenticated-orcid":false,"given":"Jun S.","family":"Wei","sequence":"additional","affiliation":[{"name":"1Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3456-4555","authenticated-orcid":false,"given":"Martha L.","family":"Bulyk","sequence":"additional","affiliation":[{"name":"8Division of Genetics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA"},{"name":"13Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Jensen","sequence":"additional","affiliation":[{"name":"4Department of Pediatrics, University of Washington School of Medicine, Seattle, WA"},{"name":"6Ben Towne Center for Childhood Cancer Research, Seattle Children\u2019s Research Institute, Seattle, WA"},{"name":"14Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6310-3467","authenticated-orcid":false,"given":"Rimas J.","family":"Orentas","sequence":"additional","affiliation":[{"name":"4Department of Pediatrics, University of Washington School of Medicine, Seattle, WA"},{"name":"6Ben Towne Center for Childhood Cancer Research, Seattle Children\u2019s Research Institute, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5858-0488","authenticated-orcid":false,"given":"Javed","family":"Khan","sequence":"additional","affiliation":[{"name":"1Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"issue":"16","key":"2023080815250498400_bib1","first-page":"1507","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia New England","volume":"371","author":"Maude","year":"2014","journal-title":"J\u00a0Med"},{"issue":"9967","key":"2023080815250498400_bib3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","article-title":"T\u00a0cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial","volume":"385","author":"Lee","year":"2015","journal-title":"Lancet"},{"issue":"16","key":"2023080815250498400_bib4","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"2023080815250498400_bib57","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1182\/blood-2014-12-580068","article-title":"CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia","volume":"125","author":"Maude","year":"2015","journal-title":"Blood"},{"issue":"5","key":"2023080815250498400_bib5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa1709919","article-title":"Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia","volume":"378","author":"Park","year":"2018","journal-title":"N Engl J Med"},{"issue":"26","key":"2023080815250498400_bib6","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1182\/blood-2016-02-629063","article-title":"CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date","volume":"127","author":"Park","year":"2016","journal-title":"Blood"},{"issue":"25","key":"2023080815250498400_bib7","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2017-02-769208","article-title":"Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation in children and young adults","volume":"129","author":"Gardner","year":"2017","journal-title":"Blood"},{"issue":"11","key":"2023080815250498400_bib8","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1038\/s41375-020-0760-x","article-title":"Serial evaluation of CD19 surface expression in pediatric B-cell malignancies following CD19-targeted therapy","volume":"34","author":"Libert","year":"2020","journal-title":"Leukemia"},{"issue":"10","key":"2023080815250498400_bib9","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1158\/2159-8290.CD-18-0442","article-title":"Tumor Antigen Escape from CAR T-cell Therapy","volume":"8","author":"Majzner","year":"2018","journal-title":"Cancer Discov"},{"issue":"5","key":"2023080815250498400_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"2023080815250498400_bib11","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1200\/JCO.20.02262","article-title":"Long-term follow-up of CD19-CAR T-cell therapy in children and young adults with B-ALL","volume":"39","author":"Shah","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"2023080815250498400_bib12","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/blood.2020006287","article-title":"Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL","volume":"137","author":"Zhao","year":"2021","journal-title":"Blood"},{"issue":"21","key":"2023080815250498400_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00383-18","article-title":"CD19 alterations emerging after CD19-directed immunotherapy cause retention of the misfolded protein in the endoplasmic reticulum","volume":"38","author":"Bagashev","year":"2018","journal-title":"Mol Cell Biol"},{"issue":"12","key":"2023080815250498400_bib14","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1158\/2159-8290.CD-15-1020","article-title":"Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 immunotherapy","volume":"5","author":"Sotillo","year":"2015","journal-title":"Cancer Discov"},{"issue":"5","key":"2023080815250498400_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/CJI.0000000000000169","article-title":"CD19 isoforms enabling resistance to CART-19 immunotherapy are expressed in B-ALL patients at initial diagnosis","volume":"40","author":"Fischer","year":"2017","journal-title":"J Immunother"},{"issue":"4","key":"2023080815250498400_bib16","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s41375-019-0580-z","article-title":"Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19","volume":"34","author":"Asnani","year":"2020","journal-title":"Leukemia"},{"issue":"3","key":"2023080815250498400_bib17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.currproblcancer.2018.04.006","article-title":"Extramedullary relapse and discordant CD19 expression between bone marrow and extramedullary sites in relapsed acute lymphoblastic leukemia after blinatumomab treatment","volume":"43","author":"Demosthenous","year":"2018","journal-title":"Curr Probl Cancer"},{"issue":"9","key":"2023080815250498400_bib18","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s00277-017-3050-6","article-title":"Lineage switch from B acute lymphoblastic leukemia to acute monocytic leukemia with persistent t(4;11)(q21;q23) and cytogeneitc evolution under CD19 targeted therapy","volume":"96","author":"Balducci","year":"2017","journal-title":"Ann Hematol"},{"issue":"20","key":"2023080815250498400_bib19","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1182\/blood-2015-08-665547","article-title":"Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy","volume":"127","author":"Gardner","year":"2016","journal-title":"Blood"},{"issue":"9","key":"2023080815250498400_bib20","doi-asserted-by":"crossref","first-page":"e607","DOI":"10.1038\/bcj.2017.89","article-title":"Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;p23) KMT2A\/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis","volume":"7","author":"Haddox","year":"2017","journal-title":"Blood Cancer J"},{"key":"2023080815250498400_bib21","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.1038\/ncomms12320","article-title":"CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity","volume":"7","author":"Jacoby","year":"2016","journal-title":"Nat Commun"},{"issue":"12","key":"2023080815250498400_bib22","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/s41591-020-1061-7","article-title":"Characteristics of antiCD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas","volume":"26","author":"Deng","year":"2020","journal-title":"Nat Med"},{"issue":"5","key":"2023080815250498400_bib23","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI125423","article-title":"CD19 CAR T cell product and disease attributes predict leukemia remission durability","volume":"129","author":"Finney","year":"2019","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"2023080815250498400_bib24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1158\/2159-8290.CD-19-0813","article-title":"Impaired death receptor signaling in leukemia causes antigen-independent resistance by inducing CAR T-cell dysfunction","volume":"10","author":"Singh","year":"2020","journal-title":"Cancer Discov"},{"issue":"12","key":"2023080815250498400_bib25","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/nmeth.2688","article-title":"Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position","volume":"10","author":"Buenrostro","year":"2013","journal-title":"Nat Methods"},{"issue":"5","key":"2023080815250498400_bib26","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1101\/gr.260877.120","article-title":"MEDEA: analysis of transcription factor binding motifs in accessible chromatin","volume":"30","author":"Mariani","year":"2020","journal-title":"Genome Res"},{"issue":"3","key":"2023080815250498400_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cels.2017.06.015","article-title":"Identification of human lineage-specific transcriptional coregulators enabled by a glossary of binding modules and tunable genomic backgrounds","volume":"5","author":"Mariani","year":"2017","journal-title":"Cell Syst"},{"issue":"1","key":"2023080815250498400_bib28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1172\/JCI131116","article-title":"Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease","volume":"130","author":"Ravell","year":"2020","journal-title":"J\u00a0Clin Invest"},{"issue":"6030","key":"2023080815250498400_bib29","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1126\/science.1198704","article-title":"Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum","volume":"332","author":"Bendall","year":"2011","journal-title":"Science"},{"issue":"8","key":"2023080815250498400_bib30","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.clml.2017.03.299","article-title":"Philadelphia chromosome-like acute lymphoblastic leukemia","volume":"17","author":"Pui","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"2023080815250498400_bib31","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.V70.4.948.948","article-title":"Clinical and biological hallmarks of the philadelphia chromosome in childhood acute lymphoblastic leukemia","volume":"70","author":"Ribeiro","year":"1987","journal-title":"Blood"},{"issue":"11","key":"2023080815250498400_bib32","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"2023080815250498400_bib33","first-page":"1985","article-title":"TEL\/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis","volume":"9","author":"Shurtleff","year":"1995","journal-title":"Leukemia"},{"issue":"5","key":"2023080815250498400_bib35","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ng.127","article-title":"An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors","volume":"40","author":"Ben-Porath","year":"2008","journal-title":"Nat Genet"},{"issue":"561","key":"2023080815250498400_bib36","doi-asserted-by":"crossref","first-page":"eabb7661","DOI":"10.1126\/scitranslmed.abb7661","article-title":"Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to the graft-versus-leukemia effect","volume":"12","author":"Bachireddy","year":"2020","journal-title":"Sci Transl Med"},{"issue":"7727","key":"2023080815250498400_bib34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41586-018-0436-0","article-title":"The genetic basis and cell of origin of mixed phenotype acute leukaemia","volume":"562","author":"Alexander","year":"2018","journal-title":"Nature"},{"key":"2023080815250498400_bib37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"W1","key":"2023080815250498400_bib38","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2023080815250498400_bib39","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.cell.2018.01.029","article-title":"The Human transcription factors","volume":"172","author":"Lambert","year":"2018","journal-title":"Cell"},{"issue":"29","key":"2023080815250498400_bib40","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1200\/JCO.2006.06.1580","article-title":"High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults","volume":"24","author":"Baldus","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"38","key":"2023080815250498400_bib41","doi-asserted-by":"crossref","first-page":"15437","DOI":"10.1073\/pnas.1213454109","article-title":"Hematopoietic overexpression of the transcription factor Erg induces lymphoid and erythro-megakaryocytic leukemia","volume":"109","author":"Carmichael","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"2023080815250498400_bib42","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1200\/JCO.2007.10.8720","article-title":"High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study","volume":"25","author":"Marcucci","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"2023080815250498400_bib43","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/ng.3691","article-title":"Deregulation of DUX4 and ERG in acute lymphoblastic leukemia","volume":"48","author":"Zhang","year":"2016","journal-title":"Nat Genet"},{"issue":"10","key":"2023080815250498400_bib44","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/ng.3646","article-title":"Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution","volume":"48","author":"Corces","year":"2016","journal-title":"Nat Genet"},{"issue":"1","key":"2023080815250498400_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13045-018-0606-4","article-title":"MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches","volume":"11","author":"Amodio","year":"2018","journal-title":"J\u00a0Hematol Oncol"},{"issue":"63","key":"2023080815250498400_bib46","doi-asserted-by":"crossref","first-page":"106527","DOI":"10.18632\/oncotarget.22507","article-title":"Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma","volume":"8","author":"Stamato","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"2023080815250498400_bib47","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood-2013-08-522094","article-title":"shRNA screening identifies JMJD1C as being required for leukemia maintenance","volume":"123","author":"Sroczynska","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2023080815250498400_bib48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/BS9.0000000000000020","article-title":"Molecular mechanisms for stemness maintenance of acute myeloid leukemia stem cells","volume":"1","author":"Wang","year":"2019","journal-title":"Blood Sci"},{"issue":"4","key":"2023080815250498400_bib49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ygeno.2009.05.006","article-title":"Evidence for potential functionality of nuclearly-encoded humanin isoforms","volume":"94","author":"Bodzioch","year":"2009","journal-title":"Genomics"},{"issue":"1-2","key":"2023080815250498400_bib50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1027372519726","article-title":"Humanin improves impaired metabolic activity and prolongs survival of serum-deprived human lymphocytes","volume":"254","author":"Kariya","year":"2003","journal-title":"Mol Cell Biochem"},{"issue":"8","key":"2023080815250498400_bib51","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1158\/0008-5472.CAN-03-3693","article-title":"CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD\/SCID mice","volume":"64","author":"Tavor","year":"2004","journal-title":"Cancer Res"},{"issue":"1","key":"2023080815250498400_bib52","doi-asserted-by":"crossref","first-page":"7305","DOI":"10.1038\/s41598-017-07848-8","article-title":"Targeting primary acute myeloid leukemia with a new CXCR4 antagonist IgG1 antibody (PF-06747143)","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"issue":"6","key":"2023080815250498400_bib53","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.4049\/jimmunol.179.6.3662","article-title":"Characterization of early stages of human B cell development by gene expression profiling","volume":"179","author":"Hystad","year":"2007","journal-title":"J\u00a0Immunol"},{"issue":"10","key":"2023080815250498400_bib54","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/eji.1830221044","article-title":"The B29 and mb-1 polypeptides are differentially expressed during human B cell differentiation","volume":"22","author":"Mason","year":"1992","journal-title":"Eur J Immunol"},{"issue":"7","key":"2023080815250498400_bib55","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1038\/s41423-021-00699-4","article-title":"Ribosomal protein S26 serves as a checkpoint of T-cell survival and homeostasis in a p53-dependent manner","volume":"18","author":"Chen","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"2023080815250498400_bib56","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/ncb3493","article-title":"Human haematopoietic stem cell lineage commitment is a continuous process","volume":"19","author":"Velten","year":"2017","journal-title":"Nat Cell Biol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/15\/4218\/2069698\/blooda_adv-2022-008977-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/15\/4218\/2069698\/blooda_adv-2022-008977-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T11:33:50Z","timestamp":1691494430000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/15\/4218\/494003\/A-stem-cell-epigenome-is-associated-with-primary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":56,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023,8,8]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022008977","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742481689.793601192","asserted-by":"object"}]},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]}}}